Cardinal Health (CAH) Stock Price, News & Analysis

Company Overview

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Key Stats

• Today's Range: $136.18 to $137.91
• 50-Day Range: $123.56 to $137.83
• 52-Week Range: $93.17 to $138.62
• Volume: 2.36 million shs
• Average Volume: 2.11 million shs
• Market Capitalization: $33.14 billion
• P/E Ratio: 25.60
• Dividend Yield: 1.47%
• Price Target: $140.14
• Consensus Rating: Moderate Buy

Cardinal Health Stock Analysis - MarketRank™

Cardinal Health scored higher than 90% of companies evaluated by MarketBeat, and ranked 87th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Cardinal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 10 buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Cardinal Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 12.58%

Earnings Growth

Earnings for Cardinal Health are expected to grow by 12.58% in the coming year, from $7.95 to $8.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cardinal Health is 25.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cardinal Health is 25.60, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.44.

Price to Earnings Growth Ratio

Cardinal Health has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.76% of the float of Cardinal Health has been sold short.

Short Interest Ratio / Days to Cover

Cardinal Health has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cardinal Health has recently increased by 2.94%, indicating that investor sentiment is decreasing.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Cardinal Health pays a meaningful dividend of 1.48%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cardinal Health has been increasing its dividend for 28 years.

Dividend Coverage

The dividend payout ratio of Cardinal Health is 37.69%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 22.57% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -2.65

Percentage of Shares Shorted

2.76% of the float of Cardinal Health has been sold short.

Short Interest Ratio / Days to Cover

Cardinal Health has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cardinal Health has recently increased by 2.94%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 4.0 / 5
• News Sentiment: 1.18

News Sentiment

Cardinal Health has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 38 news articles for Cardinal Health this week, compared to 15 articles on an average week.

Search Interest

17 people have searched for CAH on MarketBeat in the last 30 days. This is an increase of 183% compared to the previous 30 days.

MarketBeat Follows

21 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cardinal Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.09% of the stock of Cardinal Health is held by insiders.

Percentage Held by Institutions

87.17% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CAH Stock Analysis - Frequently Asked Questions

How have CAH shares performed this year?

Cardinal Health's stock was trading at $118.27 at the beginning of 2025. Since then, CAH stock has increased by 16.0% and is now trading at $137.2040.
View the best growth stocks for 2025 here.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) announced its quarterly earnings data on Thursday, January, 30th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative trailing twelve-month return on equity of 59.57% and a net margin of 0.59%.
Read the conference call transcript.

Does Cardinal Health have any subsidiaries?

The following companies are subsidiaries of Cardinal Health: Mscripts, Mirixa Corporation, Patient Recovery Business of Medtronic, TelePharm, RainTree Oncology Services, NaviHealth, Outcomes Incorporated, and others.

Who are Cardinal Health's major shareholders?

Top institutional shareholders of Cardinal Health include MassMutual Private Wealth & Trust FSB. Insiders that own company stock include Jason M Hollar, Jessica L Mayer, Stephen M Mason, Aaron E Alt, Deborah Weitzman, Ola M Snow, Michelle D Greene, Mary C Scherer and Michelle Brennan.
View institutional ownership trends.

How do I buy shares of Cardinal Health?

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardinal Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Exxon Mobil (XOM), Broadcom (AVGO), AbbVie (ABBV) and Chevron (CVX).

Company Calendar

• Record date for 1/15 Dividend: 1/02/2025
• Ex-Dividend for 1/15 Dividend: 1/02/2025
• Dividend Payable: 1/15/2025
• Last Earnings: 1/30/2025
• Today: 4/01/2025
• Record date for 4/15 Dividend: 4/01/2025
• Ex-Dividend for 4/15 Dividend: 4/01/2025
• Dividend Payable: 4/15/2025
• Next Earnings (Estimated): 5/01/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Drugs, proprietaries, & sundries
• Sub-Industry: Health Care Distributors
• Current Symbol: NYSE:CAH
• CIK: 721371
• Web: www.cardinalhealth.com
• Phone: (614) 757-5000
• Fax: 614-757-6000
• Employees: 46,500
• Year Founded: 1971

Price Target and Rating

• Average Stock Price Target: $140.14
• High Stock Price Target: $150.00
• Low Stock Price Target: $124.00
• Potential Upside/Downside: +2.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 14 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $5.36
• Trailing P/E Ratio: 25.60
• Forward P/E Ratio: 17.26
• P/E Growth: 1.49
• Net Income: $852 million
• Net Margins: 0.59%
• Pretax Margin: 0.80%
• Return on Equity: -59.57%
• Return on Assets: 4.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.02
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: $222.28 billion
• Price / Sales: 0.15
• Cash Flow: $11.35 per share
• Price / Cash Flow: 12.09
• Book Value: ($12.09) per share
• Price / Book: -11.35

Miscellaneous

• Outstanding Shares: 241,568,000
• Free Float: 241,351,000
• Market Cap: $33.14 billion
• Optionable: Optionable
• Beta: 0.66